Perspective: artemisinin-resistant malaria and the wolf.
作者信息
Meshnick Steve
出版信息
Am J Trop Med Hyg. 2012 Nov;87(5):783-784. doi: 10.4269/ajtmh.2012.12-0388.
Abstract
摘要
相似文献
1
Perspective: artemisinin-resistant malaria and the wolf.观点：青蒿素耐药性疟疾与狼。
Am J Trop Med Hyg. 2012 Nov;87(5):783-784. doi: 10.4269/ajtmh.2012.12-0388.
2
The threat of artemisinin-resistant malaria.耐青蒿素疟疾的威胁。
N Engl J Med. 2011 Sep 22;365(12):1073-5. doi: 10.1056/NEJMp1108322.
3
Prevention and treatment of artemisinin-resistant falciparum malaria: update for international travellers.青蒿素耐药恶性疟的预防与治疗：国际旅行者最新指南
Wkly Epidemiol Rec. 2010 May 21;85(21):195-6.
4
Artemisinin-resistant malaria in the Asia-Pacific region.亚太地区的青蒿素耐药性疟疾。
Lancet. 2013 Jun 1;381(9881):e16-7. doi: 10.1016/S0140-6736(12)61820-0. Epub 2012 Oct 31.
5
How genomics is contributing to the fight against artemisinin-resistant malaria parasites.基因组学如何助力对抗青蒿素耐药疟原虫。
Acta Trop. 2015 Aug;148:1-7. doi: 10.1016/j.actatropica.2015.04.007. Epub 2015 Apr 21.
6
[More artemisinin-resistant malaria in Thailand].[泰国出现更多抗青蒿素疟疾]
Tidsskr Nor Laegeforen. 2012 May 29;132(10):1223. doi: 10.4045/tidsskr.12.0529.
7
The development of artemisinin resistance in malaria: reasons and solutions.青蒿素抗药性的出现：原因与对策。
Phytother Res. 2010 Jul;24(7):1104-6. doi: 10.1002/ptr.3133.
8
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素抗性
N Engl J Med. 2009 Oct 29;361(18):1807; author reply 1808. doi: 10.1056/NEJMc091737.
9
Evidence of artemisinin-resistant malaria in western Cambodia.柬埔寨西部出现青蒿素耐药性疟疾的证据。
N Engl J Med. 2008 Dec 11;359(24):2619-20. doi: 10.1056/NEJMc0805011. Epub 2008 Dec 8.
10
Combating multidrug-resistant Plasmodium falciparum malaria.对抗耐多药恶性疟原虫疟疾
FEBS J. 2017 Aug;284(16):2569-2578. doi: 10.1111/febs.14127. Epub 2017 Jun 30.
引用本文的文献
1
Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment.恶性疟原虫中通过表观遗传赋予的环状体期对青蒿素治疗的耐受性。
Nat Commun. 2025 Aug 28;16(1):8037. doi: 10.1038/s41467-025-62479-2.
2
Isolation and characterization of blood-stage persisters by improved selection protocols using dihydroartemisinin alone.通过仅使用双氢青蒿素的改进选择方案对血液阶段持续存在的疟原虫进行分离和鉴定。
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0005324. doi: 10.1128/aac.00053-24. Epub 2025 Feb 10.
3
Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and Evolution.基因组学与遗传学：疟疾发病机制、耐药性、流行病学和进化的新见解。
Clin Microbiol Rev. 2019 Jul 31;32(4). doi: 10.1128/CMR.00019-19. Print 2019 Sep 18.
4
Pathology's historic 2019 incoming residents: Why "the internationalization of pathology" may markedly advance transfusion medicine and cellular therapeutics.病理学2019年新入职住院医师的历史性情况：为何“病理学的国际化”可能显著推动输血医学和细胞治疗学发展。
Transfus Apher Sci. 2020 Feb;59(1):102591. doi: 10.1016/j.transci.2019.07.004. Epub 2019 Jul 9.
5
Artemisinin resistance phenotypes and K13 inheritance in a cross and model.在交叉和模型中鉴定青蒿素耐药表型和 K13 遗传。
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12513-12518. doi: 10.1073/pnas.1813386115. Epub 2018 Nov 19.
6
How to combat emerging artemisinin resistance: Lessons from "The Three Little Pigs".如何应对青蒿素耐药性的出现：“三只小猪”的教训。
PLoS Pathog. 2018 Apr 26;14(4):e1006923. doi: 10.1371/journal.ppat.1006923. eCollection 2018 Apr.
7
Quantifying the pharmacology of antimalarial drug combination therapy.定量评估抗疟药物联合治疗的药理学。
Sci Rep. 2016 Sep 8;6:32762. doi: 10.1038/srep32762.
8
Characterization and optimization of the haemozoin-like crystal (HLC) assay to determine Hz inhibiting effects of anti-malarial compounds.疟原虫血红素样晶体（HLC）检测法的特性鉴定与优化，用于测定抗疟化合物对疟原虫血红素（Hz）的抑制作用。
Malar J. 2015 Oct 12;14:403. doi: 10.1186/s12936-015-0913-y.
9
Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.改变抗疟药物治疗方案可能会显著提高并恢复药物疗效。
Antimicrob Agents Chemother. 2015 Oct;59(10):6419-27. doi: 10.1128/AAC.00482-15. Epub 2015 Aug 3.
10
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?疟疾寄生虫清除率作为药物有效性和耐药性指标的稳健性如何？
Antimicrob Agents Chemother. 2015 Oct;59(10):6428-36. doi: 10.1128/AAC.00481-15. Epub 2015 Aug 3.
本文引用的文献
1
A major genome region underlying artemisinin resistance in malaria.一个主要的基因组区域是导致疟疾对青蒿素产生抗药性的原因。
Science. 2012 Apr 6;336(6077):79-82. doi: 10.1126/science.1215966.
2
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.泰国西部边境地区青蒿素耐药疟疾的出现：一项纵向研究。
Lancet. 2012 May 26;379(9830):1960-6. doi: 10.1016/S0140-6736(12)60484-X. Epub 2012 Apr 5.
3
HIV-associated Pneumocystis pneumonia.人类免疫缺陷病毒相关性肺孢子菌肺炎。
Proc Am Thorac Soc. 2011 Jun;8(3):294-300. doi: 10.1513/pats.201009-062WR.
4
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
5
Evidence of artemisinin-resistant malaria in western Cambodia.柬埔寨西部出现青蒿素耐药性疟疾的证据。
N Engl J Med. 2008 Dec 11;359(24):2619-20. doi: 10.1056/NEJMc0805011. Epub 2008 Dec 8.
6
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.在柬埔寨-泰国边境，青蒿琥酯-甲氟喹对抗恶性疟的疗效正在下降。
Emerg Infect Dis. 2008 May;14(5):716-9. doi: 10.3201/eid1405.071601.
7
Epidemiology of drug-resistant malaria.耐药疟疾的流行病学
Lancet Infect Dis. 2002 Apr;2(4):209-18. doi: 10.1016/s1473-3099(02)00239-6.
8
Artemisinin derivatives for treating uncomplicated malaria.用于治疗非复杂性疟疾的青蒿素衍生物。
Cochrane Database Syst Rev. 2000;1999(2):CD000256. doi: 10.1002/14651858.CD000256.
9
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.青蒿素与抗疟内过氧化物：从草药疗法到靶向化疗
Microbiol Rev. 1996 Jun;60(2):301-15. doi: 10.1128/mr.60.2.301-315.1996.
Zotero 插件